HDAC3 and fatty liver disease: The co-localization of the circadian nuclear receptor REV-ERBα with HDAC3 has been shown to regulate lipid metabolism which is further evidenced by the occurrence of hepatic steatosis in mice with selective deletion of either HDAC3 or REV-ERBα in the liver [121].